iMDsoft® announced that Sunnybrook Health Sciences Centre in Canada is now live with the MetaVision clinical information system throughout their critical care environment. The system has been implemented in adult, neonatal and burn intensive care units, across a total of 145 beds.
Sunnybrook Health Sciences Centre has 1.2 million patient visits each year and is home to Canada’s largest trauma centre. Two hundred scientists and clinician-scientists conduct more than a hundred million dollars of breakthrough research each year.
The centre now has complete and accurate electronic medical records and tools for clinical assessment, treatment and care planning. Advanced decision support options promote the delivery of best practices, protocols and regulatory requirements. MetaVision was adapted to support the centre’s workflow and integration requirements and to expedite reporting.
MetaVision is successfully implemented in all types of ICUs across the globe. The system’s robust architecture meets the challenges set by these high-need, data-rich environments, which have specific treatment regimens. In the NICU, for example, MetaVision offers unique functionality such as drug and fluid management supporting micro-dosages and precise calculations of nutrition requirements.
“We’re very pleased to begin using MetaVision at Sunnybrook,” said Debra Carew, Operations Director, Trauma, Emergency, and Critical Care Program, Sunnybrook Health Sciences Centre. “This is one of the first clinical documentation systems of this magnitude in the hospital, and we’re looking forward to how this will positively impact care of our patients.”
“We are pleased that Sunnybrook is joining the 350 hospitals world-wide that have chosen MetaVision. Together we look forward to improving patient care and safety in these complex departments,” said Shahar Sery, Executive Vice President of iMDsoft. “MetaVision provides deeper insight into patient care and offers a rich repository of patient data that Sunnybrook can use for quality improvement initiatives and for producing clinical studies.”
